Cite

HARVARD Citation

    Brandes, J. et al. (2020). The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response. Cephalalgia. pp. 28-38. [Online]. 
  
Back to record